Yang, H., Wang, R., Peng, S., Chen, L., Li, Q., & Wang, W. (2016). Hepatocyte growth factor reduces sensitivity to the epidermal growth factor receptor-tyrosine kinase inhibitor, gefitinib, in lung adenocarcinoma cells harboring wild-type EGFR. Oncotarget.
Citação norma ChicagoYang, Hua, Rong Wang, Shunli Peng, Longhua Chen, Qi Li, and Wei Wang. "Hepatocyte Growth Factor Reduces Sensitivity to the Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor, Gefitinib, in Lung Adenocarcinoma Cells Harboring Wild-type EGFR." Oncotarget 2016.
Citação norma MLAYang, Hua, et al. "Hepatocyte Growth Factor Reduces Sensitivity to the Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor, Gefitinib, in Lung Adenocarcinoma Cells Harboring Wild-type EGFR." Oncotarget 2016.